Home » Media

Media

International Program Spotlights the BRICs at the 2013 BIO International Convention
With one-third of all attendees international, the 2013 BIO International Convention will host a wide range of programming focused on new opportunities...
Farmers Increasingly Favor Biotech Crops
The ISAAA report, Global Status of Commercialized Biotech/GM Crops: 2012, says a record 17.3 million farmers in 28 countries are growing biotech crops on 420...

Press Releases

BIO Encouraged By House GOP Drug Benefit Plan
Apr 12 2000
WASHINGTON, D.C., (April 12, 2000) Nancy Bradish Myers, health-care policy and reimbursement counsel for the Biotechnology Industry Organization (BIO), issued...
BIO Statement Regarding National Research Council Press Release on Genetically Modified Plants
Apr 5 2000
(Dr. Val Giddings, vice president for food and agriculture of the Biotechnology Industry Organization (BIO) today made the following comments in response to...
BIO Supports Findings of National Research Council Report Regarding Genetically Modified Plants
Apr 5 2000
WASHINGTON (April 5, 2000) Recommendations put forth today in a National Research Council report entitled Genetically Modified Pest Protected Plants: Science...
BIO Praises Clinton Reassurances Regarding Gene Patents and PTO Leadership
Apr 5 2000
WASHINGTON, D.C. (April 5, 2000) The Biotechnology Industry Organization (BIO) applauded President Clinton for comments today clarifying his March 14 joint...
BIO Elects Board Members, Officers for 2000-2001
Apr 4 2000
WASHINGTON (April 3, 2000) The Biotechnology Industry Organization (BIO) today announced as chairman of the board of directors, Mark Skaletsky, president and...
BIO Response to Reps. Kucinich and Metcalf Regarding National Academy of Sciences Report
Apr 4 2000
(Carl B. Feldbaum, president of BIO, today issued the following statement regarding a request by Reps. Dennis Kucinich (D-Ohio) and Jack Metcalf (R-Wash.) to...
PUBLIC INFORMATION PROGRAM ON BIOTECHNOLOGY BEGINS APRIL 3
Apr 3 2000
Washington - April 3, 2000 - A multi-year, industry-led public information program begins today to share information about agricultural biotechnology with...
BIO 2000 Breaks Records: Most Successful Biotech Conference Ever!
Mar 30 2000
BOSTON Bio 2000 broke all previous records for attendance and involvement by scientists, academic researchers, company executives, patient advocates,...
BIO Opposes Bill Introduced by Senator Moynihan
Mar 30 2000
WASHINGTON (March 30, 2000) - The Biotechnology IndustryOrganization (BIO) issued the following statement in response to legislation introduced by Senator...
Genentech Awarded Helix Award for Corporate Excellence
Mar 29 2000
BOSTON (March 29, 2000)Genentech, Inc. today receivedthe 2000 Helix Award during the BIO 2000 International Biotechnology Meeting and Exhibition sponsored by...


Biotechnology News

Idera Announces Presentation at AAD Annual Meeting Demonstrating Toll-like Receptor Antagonists Normalize Expression of Inflammatory Genes in Psoriasis Model
March 2, 2013

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Idera presented new data showing that its selective Toll-like receptor antagonists normalized the gene expression of important cytokines...

Oral Apremilast Achieves Statistical Significance for the Primary Endpoint of PASI-75 in the First Phase III Study (ESTEEM 1) in Patients with Psoriasis
March 2, 2013

BOUDRY, Switzerland--(BUSINESS WIRE)--Celgene International Sàrl, a subsidiary of Celgene Corporation (NASDAQ: CELG) today presented the results from ESTEEM 1, the Company...

KYTHERA Biopharmaceuticals, Inc. Announces Positive Interim Results from Open-Label Study of ATX-101 in the Reduction of Unwanted Submental Fat (SMF) or “Double Chin”
March 2, 2013

MIAMI BEACH, Fla.--(BUSINESS WIRE)--KYTHERA Biopharmaceuticals, Inc. (NASDAQ: KYTH) today announced positive interim results from a Phase IIIb, multi-center, open-label...

‘Stop Runaway Drug Pricing’ Measure Qualifies for San Francisco Ballot, says the Committee on Fair Drug Pricing (a.k.a. FAIR)
March 1, 2013

SAN FRANCISCO--(BUSINESS WIRE)--‘Stop Runaway Drug Pricing’ Measure Qualifies for San Francisco Ballot, says Committee on Fair Drug Pricing (a.k.a. FAIR)-Coalition of...

Gilead Sciences to Present at the Cowen & Company 33rd Annual Health Care Conference on Monday, March 4
March 1, 2013

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that its corporate presentation will be webcast from the Cowen and Company 33rd...